Market Overview

UPDATE: Mizuho Concludes A Significant Number Of Acthar-treated Patients May Be Covered Under Medicare/Medicaid, Believes System Costs Are Highly Rebated And Inaccurately Represented On The Drug Spending Dashboards

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MNK

DateFirmActionFromTo
Nov 2017OppenheimerDowngradesOutperformPerform
Nov 2017UBSDowngradesBuyNeutral
Nov 2017Canaccord GenuityMaintainsHold

View More Analyst Ratings for MNK
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

 

Related Articles (MNK)